Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
The current Incyte(INCY) stock price is $129.60, with a market capitalization of 26.28B. The stock trades at a price-to-earnings (P/E) ratio of 16.21.
On 2026-08-21, Incyte(INCY) stock traded between a low of $126.26 and a high of $129.60. Shares are currently priced at $129.60, which is +2.6% above the low and 0.0% below the high.
The Incyte(INCY)'s current trading volume is 191.99K, compared to an average daily volume of 1.27M.
In the last year, Incyte(INCY) shares hit a 52-week high of $132.60 and a 52-week low of $81.09.
In the last year, Incyte(INCY) shares hit a 52-week high of $132.60 and a 52-week low of $81.09.
INCY News
New insider activity at Incyte ( (INCY) ) has taken place on August 20, 2026. Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with TipRanks...
...
Canaccord initiated coverage of Incyte (INCY) with a Buy rating and $152 price target Published first on TheFly – the ultimate source for real-time, market-mov...
Analyst ratings
52%
of 31 ratingsMore INCY News
Incyte, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on the...
Incyte stock has delivered a strong 90.6% return over the past three years, yet on broad valuation checks it no longer looks like an obvious bargain. Over the...
Incyte (INCY) is expected to report updated data for KRAS G12D inhibitor ‘734, in combination with mFOLFIRINOX and GemNabP, at ESMO in October, with previous da...
Piper Sandler analyst Allison Bratzel raised the firm’s price target on Incyte (INCY) to $130 from $110 and keeps an Overweight rating on the shares following q...
Incyte ((INCY)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.